PROTEK Group is one of the largest pharmaceutical companies in Russia
The Group has a diversified business structure, it operates in all pharmaceutical sectors: production of medications, distribution of health and beauty products and retail sales.
Our figures
PROTEK Group is a public company, its shares are listed on MOEX (prtk tiker)
18 250
The total number of employees of the Group.
RUB 265,6 billion
The Group’s audited consolidated revenue in 2019.
PROTEK Group strengths:
-
Leadership in all segments of pharmaceutical marketProduction - Distribution – Retail sales
-
Financial sustainability and reliabilityZero net debt position, very strong balance sheet
-
Competitive serviceReliable service for all clients and suppliers
-
Business diversificationSynergy between all segments of the Group
-
GMP-compatible production capacityLarge investments in Production segment
IFRS (International Financial Reporting Standards)
PROTEK Group complies with up-to-date standards in financial management and reporting. Corporate financial reporting is fully in line with International Financial Reporting Standards (IFRS).
Quality management
Vertical integration of companies within the Group enables a strong quality control of products at all stages of product chain, allows to quickly and adequately respond to all needs of the market, also makes our competitive positions more sustainable.
